Ginkgo Bioworks Holdings, Inc. (DNA)
8.79
-0.56
(-5.99%)
USD |
NYSE |
Feb 12, 16:00
8.84
+0.05
(+0.57%)
Pre-Market: 09:21
Ginkgo Bioworks Holdings EPS Diluted (Quarterly) : -1.452 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| Zenas BioPharma, Inc. | -1.222 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.76M |
| Revenue (Quarterly) | 38.84M |
| Total Expenses (Quarterly) | 119.59M |
| Enterprise Value | 484.79M |
| Gross Profit Margin (Quarterly) | 30.56% |
| Profit Margin (Quarterly) | -207.9% |
| Earnings Yield | -70.83% |
| Normalized Earnings Yield | -70.27 |